aluates Reports

$ 0.0

Automative

Global Nanotechnology Drug Delivery Systems Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-20T12594

Global Nanotechnology Drug Delivery Systems Industry Research Report Growth Trends and Competitive Analysis 2022 2028

BUY CHAPTERS

Global Nanotechnology Drug Delivery Systems Market Research Report 2025

Code: QYRE-Auto-20T12594

Report

June 2025

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Amgen Inc

Celgene Corporation

Johnson & Johnson

Merck& Co. Inc

Novartis International AG

Perrigo Company plc

Pfizer Inc

Teva Pharmaceutical Industries Ltd

Zosano Pharma

Becton-Dickinson（BD）Technologies

Nanopass Technologies

Corium

Valeritas

Nitto

Microdermics

TheraJect

Vaxxas

Lohmann Therapie-Systeme AG

Nanotechnology Drug Delivery Systems Market Size

The global market for Nanotechnology Drug Delivery Systems was valued at US$ 4780 million in the year 2024 and is projected to reach a revised size of US$ 5668 million by 2031, growing at a CAGR of 2.5% during the forecast period.

Nanotechnology Drug Delivery Systems Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Nanotechnology Drug Delivery Systems, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nanotechnology Drug Delivery Systems.

The Nanotechnology Drug Delivery Systems market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Nanotechnology Drug Delivery Systems market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nanotechnology Drug Delivery Systems companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Nanotechnology Drug Delivery Systems Market Report

Report Metric	Details
Report Name	Nanotechnology Drug Delivery Systems Market
Accounted market size in year	US$ 4780 million
Forecasted market size in 2031	US$ 5668 million
CAGR	2.5%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Nanocrystals Nanoparticles Dendrimers Gold Nanoparticles Fullerenes Liposomes Nanotubes Others
Segment by Application	Immunology Cardiovascular Neurology Oncology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., 3M, Zosano Pharma, Becton-Dickinson（BD）Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Nanotechnology Drug Delivery Systems company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Nanotechnology Drug Delivery Systems Market growing?

Ans: The Nanotechnology Drug Delivery Systems Market witnessing a CAGR of 2.5% during the forecast period 2025-2031.

What is the Nanotechnology Drug Delivery Systems Market size in 2031?

Ans: The Nanotechnology Drug Delivery Systems Market size in 2031 will be US$ 5668 million.

Who are the main players in the Nanotechnology Drug Delivery Systems Market report?

Ans: The main players in the Nanotechnology Drug Delivery Systems Market are AbbVie, Inc., Amgen Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Perrigo Company plc, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., 3M, Zosano Pharma, Becton-Dickinson（BD）Technologies, Nanopass Technologies, Corium, Valeritas, Nitto, Microdermics, TheraJect, Vaxxas, Lohmann Therapie-Systeme AG

What are the Application segmentation covered in the Nanotechnology Drug Delivery Systems Market report?

Ans: The Applications covered in the Nanotechnology Drug Delivery Systems Market report are Immunology, Cardiovascular, Neurology, Oncology, Others

What are the Type segmentation covered in the Nanotechnology Drug Delivery Systems Market report?

Ans: The Types covered in the Nanotechnology Drug Delivery Systems Market report are Nanocrystals, Nanoparticles, Dendrimers, Gold Nanoparticles, Fullerenes, Liposomes, Nanotubes, Others

Recommended Reports

Drug Delivery Technologies

Specialized Delivery Devices

Ocular and Microneedle Systems

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Nanocrystals

1.2.3 Nanoparticles

1.2.4 Dendrimers

1.2.5 Gold Nanoparticles

1.2.6 Fullerenes

1.2.7 Liposomes

1.2.8 Nanotubes

1.2.9 Others

1.3 Market by Application

1.3.1 Global Nanotechnology Drug Delivery Systems Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Immunology

1.3.3 Cardiovascular

1.3.4 Neurology

1.3.5 Oncology

1.3.6 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Nanotechnology Drug Delivery Systems Market Perspective (2020-2031)

2.2 Global Nanotechnology Drug Delivery Systems Growth Trends by Region

2.2.1 Global Nanotechnology Drug Delivery Systems Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Nanotechnology Drug Delivery Systems Historic Market Size by Region (2020-2025)

2.2.3 Nanotechnology Drug Delivery Systems Forecasted Market Size by Region (2026-2031)

2.3 Nanotechnology Drug Delivery Systems Market Dynamics

2.3.1 Nanotechnology Drug Delivery Systems Industry Trends

2.3.2 Nanotechnology Drug Delivery Systems Market Drivers

2.3.3 Nanotechnology Drug Delivery Systems Market Challenges

2.3.4 Nanotechnology Drug Delivery Systems Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Nanotechnology Drug Delivery Systems Players by Revenue

3.1.1 Global Top Nanotechnology Drug Delivery Systems Players by Revenue (2020-2025)

3.1.2 Global Nanotechnology Drug Delivery Systems Revenue Market Share by Players (2020-2025)

3.2 Global Nanotechnology Drug Delivery Systems Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Nanotechnology Drug Delivery Systems Revenue

3.4 Global Nanotechnology Drug Delivery Systems Market Concentration Ratio

3.4.1 Global Nanotechnology Drug Delivery Systems Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Nanotechnology Drug Delivery Systems Revenue in 2024

3.5 Global Key Players of Nanotechnology Drug Delivery Systems Head office and Area Served

3.6 Global Key Players of Nanotechnology Drug Delivery Systems, Product and Application

3.7 Global Key Players of Nanotechnology Drug Delivery Systems, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Nanotechnology Drug Delivery Systems Breakdown Data by Type

4.1 Global Nanotechnology Drug Delivery Systems Historic Market Size by Type (2020-2025)

4.2 Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Type (2026-2031)

5 Nanotechnology Drug Delivery Systems Breakdown Data by Application

5.1 Global Nanotechnology Drug Delivery Systems Historic Market Size by Application (2020-2025)

5.2 Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Nanotechnology Drug Delivery Systems Market Size (2020-2031)

6.2 North America Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025)

6.4 North America Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Nanotechnology Drug Delivery Systems Market Size (2020-2031)

7.2 Europe Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025)

7.4 Europe Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size (2020-2031)

8.2 Asia-Pacific Nanotechnology Drug Delivery Systems Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2020-2025)

8.4 Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Nanotechnology Drug Delivery Systems Market Size (2020-2031)

9.2 Latin America Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025)

9.4 Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Nanotechnology Drug Delivery Systems Market Size (2020-2031)

10.2 Middle East & Africa Nanotechnology Drug Delivery Systems Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025)

10.4 Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 AbbVie, Inc.

11.1.1 AbbVie, Inc. Company Details

11.1.2 AbbVie, Inc. Business Overview

11.1.3 AbbVie, Inc. Nanotechnology Drug Delivery Systems Introduction

11.1.4 AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.1.5 AbbVie, Inc. Recent Development

11.2 Amgen Inc.

11.2.1 Amgen Inc. Company Details

11.2.2 Amgen Inc. Business Overview

11.2.3 Amgen Inc. Nanotechnology Drug Delivery Systems Introduction

11.2.4 Amgen Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.2.5 Amgen Inc. Recent Development

11.3 Celgene Corporation

11.3.1 Celgene Corporation Company Details

11.3.2 Celgene Corporation Business Overview

11.3.3 Celgene Corporation Nanotechnology Drug Delivery Systems Introduction

11.3.4 Celgene Corporation Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.3.5 Celgene Corporation Recent Development

11.4 Johnson & Johnson

11.4.1 Johnson & Johnson Company Details

11.4.2 Johnson & Johnson Business Overview

11.4.3 Johnson & Johnson Nanotechnology Drug Delivery Systems Introduction

11.4.4 Johnson & Johnson Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.4.5 Johnson & Johnson Recent Development

11.5 Merck & Co., Inc.

11.5.1 Merck & Co., Inc. Company Details

11.5.2 Merck & Co., Inc. Business Overview

11.5.3 Merck & Co., Inc. Nanotechnology Drug Delivery Systems Introduction

11.5.4 Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.5.5 Merck & Co., Inc. Recent Development

11.6 Novartis International AG

11.6.1 Novartis International AG Company Details

11.6.2 Novartis International AG Business Overview

11.6.3 Novartis International AG Nanotechnology Drug Delivery Systems Introduction

11.6.4 Novartis International AG Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.6.5 Novartis International AG Recent Development

11.7 Perrigo Company plc

11.7.1 Perrigo Company plc Company Details

11.7.2 Perrigo Company plc Business Overview

11.7.3 Perrigo Company plc Nanotechnology Drug Delivery Systems Introduction

11.7.4 Perrigo Company plc Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.7.5 Perrigo Company plc Recent Development

11.8 Pfizer, Inc.

11.8.1 Pfizer, Inc. Company Details

11.8.2 Pfizer, Inc. Business Overview

11.8.3 Pfizer, Inc. Nanotechnology Drug Delivery Systems Introduction

11.8.4 Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.8.5 Pfizer, Inc. Recent Development

11.9 Teva Pharmaceutical Industries Ltd.

11.9.1 Teva Pharmaceutical Industries Ltd. Company Details

11.9.2 Teva Pharmaceutical Industries Ltd. Business Overview

11.9.3 Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Introduction

11.9.4 Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.9.5 Teva Pharmaceutical Industries Ltd. Recent Development

11.10 3M

11.10.1 3M Company Details

11.10.2 3M Business Overview

11.10.3 3M Nanotechnology Drug Delivery Systems Introduction

11.10.4 3M Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.10.5 3M Recent Development

11.11 Zosano Pharma

11.11.1 Zosano Pharma Company Details

11.11.2 Zosano Pharma Business Overview

11.11.3 Zosano Pharma Nanotechnology Drug Delivery Systems Introduction

11.11.4 Zosano Pharma Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.11.5 Zosano Pharma Recent Development

11.12 Becton-Dickinson（BD）Technologies

11.12.1 Becton-Dickinson（BD）Technologies Company Details

11.12.2 Becton-Dickinson（BD）Technologies Business Overview

11.12.3 Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Introduction

11.12.4 Becton-Dickinson（BD）Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.12.5 Becton-Dickinson（BD）Technologies Recent Development

11.13 Nanopass Technologies

11.13.1 Nanopass Technologies Company Details

11.13.2 Nanopass Technologies Business Overview

11.13.3 Nanopass Technologies Nanotechnology Drug Delivery Systems Introduction

11.13.4 Nanopass Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.13.5 Nanopass Technologies Recent Development

11.14 Corium

11.14.1 Corium Company Details

11.14.2 Corium Business Overview

11.14.3 Corium Nanotechnology Drug Delivery Systems Introduction

11.14.4 Corium Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.14.5 Corium Recent Development

11.15 Valeritas

11.15.1 Valeritas Company Details

11.15.2 Valeritas Business Overview

11.15.3 Valeritas Nanotechnology Drug Delivery Systems Introduction

11.15.4 Valeritas Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.15.5 Valeritas Recent Development

11.16 Nitto

11.16.1 Nitto Company Details

11.16.2 Nitto Business Overview

11.16.3 Nitto Nanotechnology Drug Delivery Systems Introduction

11.16.4 Nitto Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.16.5 Nitto Recent Development

11.17 Microdermics

11.17.1 Microdermics Company Details

11.17.2 Microdermics Business Overview

11.17.3 Microdermics Nanotechnology Drug Delivery Systems Introduction

11.17.4 Microdermics Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.17.5 Microdermics Recent Development

11.18 TheraJect

11.18.1 TheraJect Company Details

11.18.2 TheraJect Business Overview

11.18.3 TheraJect Nanotechnology Drug Delivery Systems Introduction

11.18.4 TheraJect Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.18.5 TheraJect Recent Development

11.19 Vaxxas

11.19.1 Vaxxas Company Details

11.19.2 Vaxxas Business Overview

11.19.3 Vaxxas Nanotechnology Drug Delivery Systems Introduction

11.19.4 Vaxxas Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.19.5 Vaxxas Recent Development

11.20 Lohmann Therapie-Systeme AG

11.20.1 Lohmann Therapie-Systeme AG Company Details

11.20.2 Lohmann Therapie-Systeme AG Business Overview

11.20.3 Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Introduction

11.20.4 Lohmann Therapie-Systeme AG Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025)

11.20.5 Lohmann Therapie-Systeme AG Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Amgen Inc

Celgene Corporation

Johnson & Johnson

Merck& Co. Inc

Novartis International AG

Perrigo Company plc

Pfizer Inc

Teva Pharmaceutical Industries Ltd

Zosano Pharma

Becton-Dickinson（BD）Technologies

Nanopass Technologies

Corium

Valeritas

Nitto

Microdermics

TheraJect

Vaxxas

Lohmann Therapie-Systeme AG

List of Tables

Table 1. Global Nanotechnology Drug Delivery Systems Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Nanocrystals

Table 3. Key Players of Nanoparticles

Table 4. Key Players of Dendrimers

Table 5. Key Players of Gold Nanoparticles

Table 6. Key Players of Fullerenes

Table 7. Key Players of Liposomes

Table 8. Key Players of Nanotubes

Table 9. Global Nanotechnology Drug Delivery Systems Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Nanotechnology Drug Delivery Systems Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 11. Global Nanotechnology Drug Delivery Systems Market Size by Region (2020-2025) & (US$ Million)

Table 12. Global Nanotechnology Drug Delivery Systems Market Share by Region (2020-2025)

Table 13. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 14. Global Nanotechnology Drug Delivery Systems Market Share by Region (2026-2031)

Table 15. Nanotechnology Drug Delivery Systems Market Trends

Table 16. Nanotechnology Drug Delivery Systems Market Drivers

Table 17. Nanotechnology Drug Delivery Systems Market Challenges

Table 18. Nanotechnology Drug Delivery Systems Market Restraints

Table 19. Global Nanotechnology Drug Delivery Systems Revenue by Players (2020-2025) & (US$ Million)

Table 20. Global Nanotechnology Drug Delivery Systems Market Share by Players (2020-2025)

Table 21. Global Top Nanotechnology Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology Drug Delivery Systems as of 2024)

Table 22. Ranking of Global Top Nanotechnology Drug Delivery Systems Companies by Revenue (US$ Million) in 2024

Table 23. Global 5 Largest Players Market Share by Nanotechnology Drug Delivery Systems Revenue (CR5 and HHI) & (2020-2025)

Table 24. Global Key Players of Nanotechnology Drug Delivery Systems, Headquarters and Area Served

Table 25. Global Key Players of Nanotechnology Drug Delivery Systems, Product and Application

Table 26. Global Key Players of Nanotechnology Drug Delivery Systems, Date of Enter into This Industry

Table 27. Mergers & Acquisitions, Expansion Plans

Table 28. Global Nanotechnology Drug Delivery Systems Market Size by Type (2020-2025) & (US$ Million)

Table 29. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Type (2020-2025)

Table 30. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 31. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Type (2026-2031)

Table 32. Global Nanotechnology Drug Delivery Systems Market Size by Application (2020-2025) & (US$ Million)

Table 33. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Application (2020-2025)

Table 34. Global Nanotechnology Drug Delivery Systems Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 35. Global Nanotechnology Drug Delivery Systems Revenue Market Share by Application (2026-2031)

Table 36. North America Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 37. North America Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 38. North America Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 39. Europe Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 40. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 41. Europe Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 42. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 43. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2020-2025) & (US$ Million)

Table 44. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size by Region (2026-2031) & (US$ Million)

Table 45. Latin America Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 46. Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 47. Latin America Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 48. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 49. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2020-2025) & (US$ Million)

Table 50. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size by Country (2026-2031) & (US$ Million)

Table 51. AbbVie, Inc. Company Details

Table 52. AbbVie, Inc. Business Overview

Table 53. AbbVie, Inc. Nanotechnology Drug Delivery Systems Product

Table 54. AbbVie, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 55. AbbVie, Inc. Recent Development

Table 56. Amgen Inc. Company Details

Table 57. Amgen Inc. Business Overview

Table 58. Amgen Inc. Nanotechnology Drug Delivery Systems Product

Table 59. Amgen Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 60. Amgen Inc. Recent Development

Table 61. Celgene Corporation Company Details

Table 62. Celgene Corporation Business Overview

Table 63. Celgene Corporation Nanotechnology Drug Delivery Systems Product

Table 64. Celgene Corporation Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 65. Celgene Corporation Recent Development

Table 66. Johnson & Johnson Company Details

Table 67. Johnson & Johnson Business Overview

Table 68. Johnson & Johnson Nanotechnology Drug Delivery Systems Product

Table 69. Johnson & Johnson Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 70. Johnson & Johnson Recent Development

Table 71. Merck & Co., Inc. Company Details

Table 72. Merck & Co., Inc. Business Overview

Table 73. Merck & Co., Inc. Nanotechnology Drug Delivery Systems Product

Table 74. Merck & Co., Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 75. Merck & Co., Inc. Recent Development

Table 76. Novartis International AG Company Details

Table 77. Novartis International AG Business Overview

Table 78. Novartis International AG Nanotechnology Drug Delivery Systems Product

Table 79. Novartis International AG Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 80. Novartis International AG Recent Development

Table 81. Perrigo Company plc Company Details

Table 82. Perrigo Company plc Business Overview

Table 83. Perrigo Company plc Nanotechnology Drug Delivery Systems Product

Table 84. Perrigo Company plc Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 85. Perrigo Company plc Recent Development

Table 86. Pfizer, Inc. Company Details

Table 87. Pfizer, Inc. Business Overview

Table 88. Pfizer, Inc. Nanotechnology Drug Delivery Systems Product

Table 89. Pfizer, Inc. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 90. Pfizer, Inc. Recent Development

Table 91. Teva Pharmaceutical Industries Ltd. Company Details

Table 92. Teva Pharmaceutical Industries Ltd. Business Overview

Table 93. Teva Pharmaceutical Industries Ltd. Nanotechnology Drug Delivery Systems Product

Table 94. Teva Pharmaceutical Industries Ltd. Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 95. Teva Pharmaceutical Industries Ltd. Recent Development

Table 96. 3M Company Details

Table 97. 3M Business Overview

Table 98. 3M Nanotechnology Drug Delivery Systems Product

Table 99. 3M Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 100. 3M Recent Development

Table 101. Zosano Pharma Company Details

Table 102. Zosano Pharma Business Overview

Table 103. Zosano Pharma Nanotechnology Drug Delivery Systems Product

Table 104. Zosano Pharma Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 105. Zosano Pharma Recent Development

Table 106. Becton-Dickinson（BD）Technologies Company Details

Table 107. Becton-Dickinson（BD）Technologies Business Overview

Table 108. Becton-Dickinson（BD）Technologies Nanotechnology Drug Delivery Systems Product

Table 109. Becton-Dickinson（BD）Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 110. Becton-Dickinson（BD）Technologies Recent Development

Table 111. Nanopass Technologies Company Details

Table 112. Nanopass Technologies Business Overview

Table 113. Nanopass Technologies Nanotechnology Drug Delivery Systems Product

Table 114. Nanopass Technologies Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 115. Nanopass Technologies Recent Development

Table 116. Corium Company Details

Table 117. Corium Business Overview

Table 118. Corium Nanotechnology Drug Delivery Systems Product

Table 119. Corium Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 120. Corium Recent Development

Table 121. Valeritas Company Details

Table 122. Valeritas Business Overview

Table 123. Valeritas Nanotechnology Drug Delivery Systems Product

Table 124. Valeritas Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 125. Valeritas Recent Development

Table 126. Nitto Company Details

Table 127. Nitto Business Overview

Table 128. Nitto Nanotechnology Drug Delivery Systems Product

Table 129. Nitto Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 130. Nitto Recent Development

Table 131. Microdermics Company Details

Table 132. Microdermics Business Overview

Table 133. Microdermics Nanotechnology Drug Delivery Systems Product

Table 134. Microdermics Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 135. Microdermics Recent Development

Table 136. TheraJect Company Details

Table 137. TheraJect Business Overview

Table 138. TheraJect Nanotechnology Drug Delivery Systems Product

Table 139. TheraJect Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 140. TheraJect Recent Development

Table 141. Vaxxas Company Details

Table 142. Vaxxas Business Overview

Table 143. Vaxxas Nanotechnology Drug Delivery Systems Product

Table 144. Vaxxas Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 145. Vaxxas Recent Development

Table 146. Lohmann Therapie-Systeme AG Company Details

Table 147. Lohmann Therapie-Systeme AG Business Overview

Table 148. Lohmann Therapie-Systeme AG Nanotechnology Drug Delivery Systems Product

Table 149. Lohmann Therapie-Systeme AG Revenue in Nanotechnology Drug Delivery Systems Business (2020-2025) & (US$ Million)

Table 150. Lohmann Therapie-Systeme AG Recent Development

Table 151. Research Programs/Design for This Report

Table 152. Key Data Information from Secondary Sources

Table 153. Key Data Information from Primary Sources

Table 154. Authors List of This Report

List of Figures

Figure 1. Nanotechnology Drug Delivery Systems Picture

Figure 2. Global Nanotechnology Drug Delivery Systems Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Nanotechnology Drug Delivery Systems Market Share by Type: 2024 VS 2031

Figure 4. Nanocrystals Features

Figure 5. Nanoparticles Features

Figure 6. Dendrimers Features

Figure 7. Gold Nanoparticles Features

Figure 8. Fullerenes Features

Figure 9. Liposomes Features

Figure 10. Nanotubes Features

Figure 11. Others Features

Figure 12. Global Nanotechnology Drug Delivery Systems Market Size by Application (2020-2031) & (US$ Million)

Figure 13. Global Nanotechnology Drug Delivery Systems Market Share by Application: 2024 VS 2031

Figure 14. Immunology Case Studies

Figure 15. Cardiovascular Case Studies

Figure 16. Neurology Case Studies

Figure 17. Oncology Case Studies

Figure 18. Others Case Studies

Figure 19. Nanotechnology Drug Delivery Systems Report Years Considered

Figure 20. Global Nanotechnology Drug Delivery Systems Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 21. Global Nanotechnology Drug Delivery Systems Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 22. Global Nanotechnology Drug Delivery Systems Market Share by Region: 2024 VS 2031

Figure 23. Global Nanotechnology Drug Delivery Systems Market Share by Players in 2024

Figure 24. Global Top Nanotechnology Drug Delivery Systems Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanotechnology Drug Delivery Systems as of 2024)

Figure 25. The Top 10 and 5 Players Market Share by Nanotechnology Drug Delivery Systems Revenue in 2024

Figure 26. North America Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. North America Nanotechnology Drug Delivery Systems Market Share by Country (2020-2031)

Figure 28. United States Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Canada Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Europe Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Europe Nanotechnology Drug Delivery Systems Market Share by Country (2020-2031)

Figure 32. Germany Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. France Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. U.K. Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Italy Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Russia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Nordic Countries Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Asia-Pacific Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Asia-Pacific Nanotechnology Drug Delivery Systems Market Share by Region (2020-2031)

Figure 40. China Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Japan Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. South Korea Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Southeast Asia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. India Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Australia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Latin America Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Latin America Nanotechnology Drug Delivery Systems Market Share by Country (2020-2031)

Figure 48. Mexico Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Brazil Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Middle East & Africa Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. Middle East & Africa Nanotechnology Drug Delivery Systems Market Share by Country (2020-2031)

Figure 52. Turkey Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 53. Saudi Arabia Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 54. UAE Nanotechnology Drug Delivery Systems Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 55. AbbVie, Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 56. Amgen Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 57. Celgene Corporation Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 58. Johnson & Johnson Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 59. Merck & Co., Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 60. Novartis International AG Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 61. Perrigo Company plc Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 62. Pfizer, Inc. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 63. Teva Pharmaceutical Industries Ltd. Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 64. 3M Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 65. Zosano Pharma Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 66. Becton-Dickinson（BD）Technologies Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 67. Nanopass Technologies Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 68. Corium Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 69. Valeritas Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 70. Nitto Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 71. Microdermics Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 72. TheraJect Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 73. Vaxxas Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 74. Lohmann Therapie-Systeme AG Revenue Growth Rate in Nanotechnology Drug Delivery Systems Business (2020-2025)

Figure 75. Bottom-up and Top-down Approaches for This Report

Figure 76. Data Triangulation

Figure 77. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Novel Drug Delivery Systems for Cancer Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Injectable Drug Delivery System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Nano Pharmaceutical Market Research Report 2024

Vaccine Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Vaccines Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pulmonary Drug Delivery Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmacy Dispensing System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inspection System for Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Proton Therapy Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Drug Delivery System Development Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Ophthalmic Drug Delivery Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Digital Health and Digital Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Pharmacokinetics Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Smart Drug Delivery Systems Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Robotic Pharmacy Dispensing System Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions